Public Health News and Research

RSS

New method helps detect remission points of pandemics

Lecturers from the University of Valencia, Jose M. Pavía and Ernesto Veres-Ferrer, have developed a method that makes it possible to identify, in real time, when an epidemic issue such as Covid-19 is in remission. The method, explained in a research paper, has been published in the journal Statistics in Medicine.

17 Nov 2020

First intratumoral injection approved by FDA for treating non-metastatic mast cell tumors in dogs

Today, the U.S. Food and Drug Administration approved Stelfonta (tigilanol tiglate injection) to treat dogs with non-metastatic, skin-based (cutaneous) mast cell tumors (MCTs).

17 Nov 2020

Identifying protective factors to suicide among lesbian and bisexual women

What protective factors reduce the likelihood lesbian and bisexual women will consider killing themselves? That's the focus of a $2 million national study led by researches at the UCF College of Medicine's new Population Health Sciences Department.

17 Nov 2020

Researchers look at barriers related to use of contact tracing apps

As a tool for controlling the spread of COVID-19, mobile applications for contact tracing are most effective when they are widely adopted and left on indefinitely.

16 Nov 2020

Multi-model forecasts could help inform management of COVID-19 pandemic

A team of researchers from various institutions in the UK has reviewed multi-model forecasts of the coronavirus disease 2019 (COVID-19) pandemic made between the end of March and mid-July 2020.

16 Nov 2020

OHIO professor's new study focuses on strategies hospitals adopt to address the opioid epidemic

While the world's attention to public health remains focused on COVID-19, Berkeley Franz, Ph.D., assistant professor at the Ohio University Heritage College of Osteopathic Medicine, continues to focus her attention on one of the largest public health crises in the United States today - the opioid epidemic.

16 Nov 2020

Study compares deaths in Sweden and Norway before and after COVID pandemic

A recent epidemiological study, currently available on the medRxiv preprint server, demonstrates that all-cause mortality was mostly unchanged during the coronavirus disease (COVID-19) pandemic compared to the previous four years in Norway and Sweden – two countries which took very different routes in their battle against this disease.

16 Nov 2020

Additional monitoring after cardiac surgery may be needed for patients at risk of atrial fibrillation

Atrial fibrillation (AF), an irregular heartbeat that can increase the likelihood of stroke, was detected up to 10 times more frequently in high risk patients recovering from heart surgery who wore a continuous cardiac monitor for a month, compared to patients who had usual follow-up care following their procedure, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Health care workers have a higher prevalence of COVID-19 than non-health care workers

Health care workers -- particularly nurses -- have a higher prevalence of SARS-CoV-2 infection than non-health care workers, according to researchers at Rutgers, which released baseline results from a large prospective study of participants at Rutgers and affiliated hospitals recruited during the early phase of the COVID-19 pandemic.

16 Nov 2020

New technology to diagnose fatal disease in preemies granted FDA's Breakthrough Device Designation

A technology to diagnose a potentially fatal disease in premature infants invented by Sunyoung Kim, PhD, Professor of Biochemistry & Molecular Biology at LSU Health New Orleans School of Medicine, has been granted a Breakthrough Device Designation by the Food and Drug Administration.

16 Nov 2020

Modifiable risk factors in the first 1000 days of life predict higher adiposity and cardiometabolic risk

Early life risk factors in the first 1000 days cumulatively predict higher obesity and cardiometabolic risk in early adolescence, according to new research led by the Harvard Pilgrim Health Care Institute.

16 Nov 2020

Sanger Institute and COG-UK get £12.2M funding to build genomic surveillance system for COVID-19

The Department for Health and Social Care Testing Innovation Fund has backed the Wellcome Sanger Institute and the COVID-19 Genomics UK Consortium in expanding whole genome sequencing of positive SARS-CoV-2 virus samples to map how COVID-19 spreads and evolves.

16 Nov 2020

COVID-19 outbreak on an American aircraft carrier: A case study in transmission

A new study showing the dynamics of infectious spread within close quarters of an aircraft carrier. The study presents a rich case study that may help us better understand the dynamics of SARS-CoV-2’s transmission and thereby fine-tune present policies that aim to prevent its spread.

16 Nov 2020

Antifungal agent Itraconazole inhibits SARS CoV-2 in vitro

Itraconazole is a broad-spectrum antifungal agent that has been shown to have some in vitro activity against SARS-CoV-2 by a team of Belgian and German researchers.

16 Nov 2020

Google searches for COVID-19 symptoms can anticipate case numbers

Google searches may come to the aid in predicting the evolution of the COVID-19 pandemic, which we need to identify, manage, and, if possible, contain new outbreaks.

16 Nov 2020

STRENGTH trial: Fish oil-based medication did not decrease risk of cardiac events

The fish oil-based medication known as omega-3 carboxylic acids or omega-3 CA did not decrease the risk of cardiac events compared to a placebo, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Short, one-month dual anti-platelet treatment is safe and effective after stent placement

A one-month treatment of dual anti-platelet therapy is safe and as effective as a longer duration of therapy at preventing cardiac events in patients one year after stent placement, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Potent antiplatelet drug not superior to standard of care in reducing heart attack risk during angioplasty

The use of the more potent antiplatelet medication ticagrelor was not superior to clopidogrel in the reduction of the rate of heart attack or severe complications among people undergoing an elective procedure to open a blocked artery, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

A daily dose of omega-3 fatty acids did not reduce the risk of cardiac events, including secondary heart attack, stroke, bypass surgery or death, among elderly people who had survived a recent heart attack, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Individuals with high BMI and LDL cholesterol are at increased risk of COVID-19

A new study led by researchers at Queen Mary University of London uses a novel approach to investigate the effects of cardiovascular risk factors on the risk of COVID-19 infection.

16 Nov 2020

Public Health News and Research

New method helps detect remission points of pandemics

First intratumoral injection approved by FDA for treating non-metastatic mast cell tumors in dogs

Identifying protective factors to suicide among lesbian and bisexual women

Researchers look at barriers related to use of contact tracing apps

Multi-model forecasts could help inform management of COVID-19 pandemic

OHIO professor's new study focuses on strategies hospitals adopt to address the opioid epidemic

Study compares deaths in Sweden and Norway before and after COVID pandemic

Additional monitoring after cardiac surgery may be needed for patients at risk of atrial fibrillation

Health care workers have a higher prevalence of COVID-19 than non-health care workers

New technology to diagnose fatal disease in preemies granted FDA's Breakthrough Device Designation

Modifiable risk factors in the first 1000 days of life predict higher adiposity and cardiometabolic risk

Sanger Institute and COG-UK get £12.2M funding to build genomic surveillance system for COVID-19

COVID-19 outbreak on an American aircraft carrier: A case study in transmission

Antifungal agent Itraconazole inhibits SARS CoV-2 in vitro

Google searches for COVID-19 symptoms can anticipate case numbers

STRENGTH trial: Fish oil-based medication did not decrease risk of cardiac events

Short, one-month dual anti-platelet treatment is safe and effective after stent placement

Potent antiplatelet drug not superior to standard of care in reducing heart attack risk during angioplasty

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

Individuals with high BMI and LDL cholesterol are at increased risk of COVID-19

News Medical 2025: Healthcare Shifts That Mattered Most eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News